High-flow O2 therapy feasible for infants with bronchiolitis

High-flow O<sub>2</sub> therapy feasible for infants with bronchiolitis

(HealthDay)—High-flow oxygen therapy may be more effective than standard oxygen therapy in preventing care escalation among infants with bronchiolitis treated outside an intensive care unit, according to a study published in the March 22 issue of the New England Journal of Medicine.

Donna Franklin, from Lady Cilento Children's Hospital in South Brisbane, Australia, and randomized infants (<12 months of age) who had and a need for supplemental oxygen therapy to receive either high-flow oxygen therapy or standard oxygen therapy. The analysis included 1,472 patients.

The researchers found that 12 percent of infants in the high-flow group received escalation of care due to treatment failure versus 23 percent in the standard-therapy group. However, there were no significant differences in the duration of hospital stay or the duration of oxygen therapy. One case of pneumothorax occurred in each group (<1 percent of infants). Just under two-thirds (61 percent) of the 167 infants in the standard-therapy group who had treatment failure responded to high-flow rescue therapy.

"Among with bronchiolitis who were treated outside an , those who received high-flow oxygen therapy had significantly lower rates of escalation of care due to treatment failure than those in the group that received standard oxygen therapy," the authors write.


Explore further

Practice variation in treatment for bronchiolitis in infants

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: New England Journal of Medicine

Copyright © 2018 HealthDay. All rights reserved.

Citation: High-flow O2 therapy feasible for infants with bronchiolitis (2018, March 22) retrieved 23 October 2019 from https://medicalxpress.com/news/2018-03-high-flow-o2-therapy-feasible-infants.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more